Pharmacological/Biological Effects of Berberine
Identifieur interne : 001C92 ( Istex/Curation ); précédent : 001C91; suivant : 001C93Pharmacological/Biological Effects of Berberine
Auteurs : Eva M. Galvez [Espagne] ; M. Perez [Espagne] ; P. Domingo [Espagne] ; D. Nu Ez [Espagne] ; V. L. Cebolla [Espagne] ; M. Matt [France] ; J. Pardo [Espagne]Source :
Abstract
Abstract: Berberine is a yellow alkaloid naturally produced by a diversity of plants. It is extracted from the roots, rhizome, and stem bark of several plants. This natural product has been used for centuries in the Chinese medicinal herb. Berberine presents a wide range of pharmacological applications such as antidiabetic, hypolipidemic, antihypertensive, anti-inflammatory, antioxidant, antidepressant, anticancer, antidiarrheal, hepatoprotective, and, above all, antimicrobial. It has been tested clinically in the treatment of oriental sore, diarrhea, trachoma, diabetes mellitus type 2, hypercholesterolemia, and congestive cardiac failure. This alkaloid is also used in the treatment of gastric and inflammatory diseases and more recently is being investigated for its application in neurology, cardiology, and oncology.
Url:
DOI: 10.1007/978-3-642-22144-6_182
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C92
Links to Exploration step
ISTEX:3417A3CE75F0F49DFB4152350ABBAE42EF18DA62Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacological/Biological Effects of Berberine</title><author><name sortKey="Galvez, Eva M" sort="Galvez, Eva M" uniqKey="Galvez E" first="Eva M." last="Galvez">Eva M. Galvez</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: eva@icb.csic.es</mods:affiliation><country wicri:rule="url">Espagne</country></affiliation></author><author><name sortKey="Perez, M" sort="Perez, M" uniqKey="Perez M" first="M." last="Perez">M. Perez</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Domingo, P" sort="Domingo, P" uniqKey="Domingo P" first="P." last="Domingo">P. Domingo</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Nu Ez, D" sort="Nu Ez, D" uniqKey="Nu Ez D" first="D." last="Nu Ez">D. Nu Ez</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Cebolla, V L" sort="Cebolla, V L" uniqKey="Cebolla V" first="V. L." last="Cebolla">V. L. Cebolla</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Matt, M" sort="Matt, M" uniqKey="Matt M" first="M." last="Matt">M. Matt</name><affiliation wicri:level="1"><mods:affiliation>Laboratoire de Chimie et Méthodologie pour l´environnement, Université de Metz, 1, bd Arago, 57078, Metz, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Chimie et Méthodologie pour l´environnement, Université de Metz, 1, bd Arago, 57078, Metz</wicri:regionArea></affiliation></author><author><name sortKey="Pardo, J" sort="Pardo, J" uniqKey="Pardo J" first="J." last="Pardo">J. Pardo</name><affiliation wicri:level="1"><mods:affiliation>Departamento Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Fundación Aragón I + D (ARAID), Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación Aragón I + D (ARAID), Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Grupo Inmunidad Celular Efectora (ICE), Instituto de Investigaciones Sanitarias de Aragón, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Grupo Inmunidad Celular Efectora (ICE), Instituto de Investigaciones Sanitarias de Aragón, Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, Zaragoza</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3417A3CE75F0F49DFB4152350ABBAE42EF18DA62</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1007/978-3-642-22144-6_182</idno><idno type="url">https://api.istex.fr/ark:/67375/HCB-W571QTRR-N/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001C92</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C92</idno><idno type="wicri:Area/Istex/Curation">001C92</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pharmacological/Biological Effects of Berberine</title><author><name sortKey="Galvez, Eva M" sort="Galvez, Eva M" uniqKey="Galvez E" first="Eva M." last="Galvez">Eva M. Galvez</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: eva@icb.csic.es</mods:affiliation><country wicri:rule="url">Espagne</country></affiliation></author><author><name sortKey="Perez, M" sort="Perez, M" uniqKey="Perez M" first="M." last="Perez">M. Perez</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Domingo, P" sort="Domingo, P" uniqKey="Domingo P" first="P." last="Domingo">P. Domingo</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Nu Ez, D" sort="Nu Ez, D" uniqKey="Nu Ez D" first="D." last="Nu Ez">D. Nu Ez</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Cebolla, V L" sort="Cebolla, V L" uniqKey="Cebolla V" first="V. L." last="Cebolla">V. L. Cebolla</name><affiliation wicri:level="1"><mods:affiliation>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Carboquímica, Consejo Superior de Investigaciones Científicas (CSIC), Miguel Luesma 4, 50018, Zaragoza</wicri:regionArea></affiliation></author><author><name sortKey="Matt, M" sort="Matt, M" uniqKey="Matt M" first="M." last="Matt">M. Matt</name><affiliation wicri:level="1"><mods:affiliation>Laboratoire de Chimie et Méthodologie pour l´environnement, Université de Metz, 1, bd Arago, 57078, Metz, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Chimie et Méthodologie pour l´environnement, Université de Metz, 1, bd Arago, 57078, Metz</wicri:regionArea></affiliation></author><author><name sortKey="Pardo, J" sort="Pardo, J" uniqKey="Pardo J" first="J." last="Pardo">J. Pardo</name><affiliation wicri:level="1"><mods:affiliation>Departamento Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Fundación Aragón I + D (ARAID), Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Fundación Aragón I + D (ARAID), Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Grupo Inmunidad Celular Efectora (ICE), Instituto de Investigaciones Sanitarias de Aragón, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Grupo Inmunidad Celular Efectora (ICE), Instituto de Investigaciones Sanitarias de Aragón, Zaragoza</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, Zaragoza, Spain</mods:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, Zaragoza</wicri:regionArea></affiliation></author></analytic><monogr></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Berberine is a yellow alkaloid naturally produced by a diversity of plants. It is extracted from the roots, rhizome, and stem bark of several plants. This natural product has been used for centuries in the Chinese medicinal herb. Berberine presents a wide range of pharmacological applications such as antidiabetic, hypolipidemic, antihypertensive, anti-inflammatory, antioxidant, antidepressant, anticancer, antidiarrheal, hepatoprotective, and, above all, antimicrobial. It has been tested clinically in the treatment of oriental sore, diarrhea, trachoma, diabetes mellitus type 2, hypercholesterolemia, and congestive cardiac failure. This alkaloid is also used in the treatment of gastric and inflammatory diseases and more recently is being investigated for its application in neurology, cardiology, and oncology.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C92 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001C92 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:3417A3CE75F0F49DFB4152350ABBAE42EF18DA62
|texte= Pharmacological/Biological Effects of Berberine
}}
| This area was generated with Dilib version V0.6.33. |  |